4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Neuroblastoma

4-o-methyl-12-o-tetradecanoylphorbol 13-acetate has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ben, LH; Cravens, PD; Gocke, AR; Hussain, RZ; Liu, Y; Lovett-Racke, AE; McTigue, DM; Peng, H; Puttaparthi, K; Racke, MK; Wei, P; Winger, R; Yang, Y	1
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M	1

Other Studies

2 other study(ies) available for 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Neuroblastoma

Article	Year
Silencing Nogo-A promotes functional recovery in demyelinating disease. Annals of neurology, 2010, Volume: 67, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; GAP-43 Protein; Gene Expression Regulation; Glycoproteins; Interferon-gamma; Interleukin-10; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Basic Protein; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuroblastoma; Nogo Proteins; Peptide Fragments; RNA, Small Interfering; Spinal Cord; Tetradecanoylphorbol Acetate; Transfection	2010
Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:4 Topics: Animals; Antidepressive Agents; Cell Differentiation; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Colforsin; Corticotropin-Releasing Hormone; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glucocorticoids; Humans; Mice; Molecular Biology; Neuroblastoma; Pituitary Gland; Potassium Chloride; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Transfection	2004

Article

Year

Silencing Nogo-A promotes functional recovery in demyelinating disease.

Annals of neurology, 2010, Volume: 67, Issue:4

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; GAP-43 Protein; Gene Expression Regulation; Glycoproteins; Interferon-gamma; Interleukin-10; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Basic Protein; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuroblastoma; Nogo Proteins; Peptide Fragments; RNA, Small Interfering; Spinal Cord; Tetradecanoylphorbol Acetate; Transfection

2010

Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:4

Topics: Animals; Antidepressive Agents; Cell Differentiation; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Colforsin; Corticotropin-Releasing Hormone; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glucocorticoids; Humans; Mice; Molecular Biology; Neuroblastoma; Pituitary Gland; Potassium Chloride; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Transfection

2004